After chipping away for years at claims that Procter & Gamble’s Fixodent denture glue can cause neurological damage, P&G’s lawyers at Weil, Gotshal & Manges reached what looked like a breakthrough in late January, more than half a decade into the case. This week that ruling formally knocked out the last of the claims in the consolidated litigation, with the last of the dismissals lodged on Thursday.
On Jan. 28, U.S. District Judge Cecilia Altonaga in Miami found that plaintiffs lawyers had offered flawed evidence in support of a theory that the zinc in Fixodent has a causal link to neurological damage. The ruling kept the plaintiffs’ causation expert from testifying and undermined the claims of injury in the denture cream case, which dates back to June 2009.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
